It has been reported that TBK1 is increased in palmitic acid (PA)-treated liver cells (especially in liver Kupffer cells), suggesting its potential role in the progression of NAFLD to NASH. Here, TBK1 is linked to metabolic dysfunction-associated steatohepatitis.